Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Carboplatin Injection
Status: Currently in Shortage
»Date first posted:
04/28/2023
»Therapeutic Categories: Oncology
Accord Healthcare Inc. (Reverified 05/01/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-34) | Unavailable | Estimated recovery: TBD | Requirements related to complying with good manufacturing practices |
| Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-12) | Unavailable | Estimated recovery: TBD | Requirements related to complying with good manufacturing practices |
| Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-33) | Unavailable | Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug |
| Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-31) | Unavailable | Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug |
Avyxa Pharma, LLC (New 05/07/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Kyxata, Injection, 80 mg/8 mL (10 mg/mL) (NDC 83831-141-08) | Available | ||
| Kyxata, Injection, 500 mg/50 mL (10 mg/mL) (NDC 83831-142-50) | Available |
Eugia US LLC (Revised 05/05/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Carboplatin, Injection, 450 mg/45 mL (NDC 55150-335-01) | Unavailable | Estimated recovery: TBD; check wholesalers for inventory | Demand increase for the drug |
| Carboplatin, Injection, 600 mg/60 mL (NDC 55150-386-01) | Unavailable | Estimated recovery: TBD; check wholesalers for inventory | Demand increase for the drug |
Fresenius Kabi USA, LLC (Reverified 04/23/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Carboplatin, Injection, 10 mg/1 mL (NDC 63323-172-60) | Unavailable | Next release April 2026. Check wholesalers for inventory. | Delay in shipping of the drug |
Gland Pharma Limited (Reverified 04/24/2026)
Company Contact Information:
Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270
Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Carboplatin, Injection, 50mg/5mL (NDC 54288-164-01) | Unavailable | Discontinued; Distributed by BPI Labs, LLC | Discontinuation of the manufacture of the drug |
| Carboplatin, Injection, 150mg/15mL (NDC 54288-165-01) | Limited Availability | Estimated recovery: end of August 2026; Distributed by BPI Labs, LLC | Demand increase for the drug |
| Carboplatin, Injection, 450mg/45mL (NDC 54288-166-01) | Limited Availability | Estimated recovery: end of June 2026; Distributed by BPI Labs, LLC | Demand increase for the drug |
| Carboplatin, Injection, 600 mg/65 mL (NDC 54288-167-01) | Limited Availability | Estimated recovery: end of June 2026; Distributed by BPI Labs, LLC | Demand increase for the drug |
Hospira, Inc., a Pfizer Company (Revised 05/05/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose ONCO-TAIN™ Glass Fliptop Vial (NDC 61703-339-18) | Available | ||
| Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Novaplus® Multiple Dose ONCO-TAIN™ Vial (NDC 61703-360-18) | Available | ||
| Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose ONCO-TAIN™ Glass Fliptop Vial (NDC 61703-339-22) | Limited Availability | Limited Supply Available. Next Delivery: May 2026; Estimated Recovery: July 2026 | Demand increase for the drug |
| Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Novaplus® Multiple Dose ONCO-TAIN™ Vial (NDC 61703-150-05) | Available | ||
| Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose ONCO-TAIN™ Glass Fliptop Vial (NDC 61703-339-50) | Unavailable | Next Delivery: June 2026; Estimated Recovery: September 2026 | Demand increase for the drug |
| Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Novaplus® Multiple Dose ONCO-TAIN™ Vial (NDC 61703-262-05) | Limited Availability | Limited Supply Available. Next Delivery: June 2026; Estimated recovery: September 2026 | Demand increase for the drug |
| Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose ONCO-TAIN™ Glass Fliptop Vial (NDC 61703-339-56) | Available | ||
| Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Novaplus® Multiple Dose ONCO-TAIN™ Vial (NDC 61703-600-05) | Unavailable | Next delivery: May 2026; Estimated Recovery: June 2026 | Demand increase for the drug |
Teva Pharmaceuticals USA, Inc. (Revised 05/01/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4244-01) | Limited Availability | Estimated recovery: November 2026 | Other |
| Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4246-01) | Limited Availability | Estimated recovery: May 2026 | Other |
| Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4248-01) | Limited Availability | Estimated recovery: November 2026 | Other |
| Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4239-01) | Limited Availability | Estimated recovery: June 2026 | Other |
Teyro Labs (Reverified 04/20/2026)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-1) | Unavailable | Discontinuation of the manufacture of the drug. | Discontinuation of the manufacture of the drug |
| Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3) | Unavailable | Discontinuation of the manufacture of the drug. | Discontinuation of the manufacture of the drug |
| Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6) | Unavailable | Discontinuation of the manufacture of the drug. | Discontinuation of the manufacture of the drug |
| Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7) | Unavailable | Discontinuation of the manufacture of the drug. | Discontinuation of the manufacture of the drug |